eClinicalWorks — and some of its executives and employees — agreed to pay $155 million to resolve allegations it violated the False Claims Act, the Department of Justice announced May 31. The government alleged eClinicalWorks withheld information from its certifying entity, such as how its software reportedly wasn’t able to meet certain criteria for standardized drug codes.
Reaction Data surveyed 113 healthcare professionals — including physicians and executives — about their attitude toward the Westborough, Mass.-based EHR vendor and its competitors.
Here are five survey insights.
1. The plurality of eClinicalWorks customers (41 percent) were not aware of the settlement. Only 14 percent of customers indicated they were following the news closely.
2. Almost half of eClinicalWorks customers (48 percent) said they would complete their eClinicalWorks contract and then reevaluate, while 22 percent said the settlement did not impact their relationship with the vendor.
3. The majority of non-eClinicalWorks customers (61 percent) were not aware of the settlement.
4. Twenty-seven percent of non-eClinicalWorks customers said the settlement decreased their confidence in their current vendor
5. The majority of respondents (71 percent) indicated they were extremely unlikely to consider eClinicalWorks in the future.
Click here to view the full survey.
More articles on health IT:
6 most-funded digital health services, as ranked by Rock Health
Hyperledger collaborative rolls out 1st production-ready blockchain code
Ontario government invests $1.5M in health incentives app
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
